Insulet Corporation (PODD) Free Cash Flow
Insulet Corporation (PODD) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$6.20M |
| 2017-12-31 | -$36.02M |
| 2018-12-31 | -$126.50M |
| 2019-12-31 | -$72.50M |
| 2020-12-31 | -$82.50M |
| 2021-12-31 | -$180.00M |
| 2022-12-31 | -$38.30M |
| 2023-12-31 | $36.50M |
| 2024-12-31 | $296.20M |
| 2025-12-31 | $349.90M |
How PODD compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ALGN | Align Technology Inc. | $490.78M |
| ALNY | Alnylam Pharmaceuticals Inc. | $465.38M |
| BIO | Bio-Rad Laboratories Inc. Class A | $374.60M |
| HAE | Haemonetics Corporation | $260.44M |
| MMSI | Merit Medical Systems Inc. | $212.53M |
These are five companies in the same sector as PODD with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Insulet Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("PODD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PODD | $145.42 | -1.85% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 |